Cidara Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Cidara Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$96M, a 1322% decline year-over-year.
  • Cidara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$127M, a 3798% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.5M, a 26.9% increase from 2022.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$33.5M, a 20.7% increase from 2021.
  • Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$42.3M, a 41.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$24.5M +$9.02M +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-22
2022 -$33.5M +$8.75M +20.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-22
2021 -$42.3M +$29.6M +41.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$71.8M -$30.1M -72.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$41.7M +$21.6M +34.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
2018 -$63.3M -$7.56M -13.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$55.7M -$7.29M -15% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-04
2016 -$48.4M -$16.1M -49.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$32.3M -$20.7M -178% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$11.6M -$10.5M -974% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$1.08M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.